Furthermore, a method for lung cancer and/or esophageal cancer treatment and prevention based on the overexpression of CDCA5 was developed and patented, proving the possible application of CDCA5 to cancer therapeutics [24]. Here, CDCA5 is linked to lung carcinoma.